June 2, 2020 / 12:12 PM / a month ago

BRIEF-AgeX Therapeutics And ImStem Biotechnology Sign Non-Binding Letter Of Intent

June 2 (Reuters) - AgeX Therapeutics Inc:

* AGEX THERAPEUTICS AND IMSTEM BIOTECHNOLOGY SIGN NON-BINDING LETTER OF INTENT REGARDING INVESTIGATIONAL MSC CANDIDATE IMS001 FOR COVID-19 AND OTHER CAUSES OF ARDS

* AGEX THERAPEUTICS - EMERGING PRECLINICAL AND CLINICAL LITERATURE SUPPORT MSCS MAY BE APPROPRIATE TO DEVELOP FOR COVID-19 AS WELL AS NON-COVID-19 ARDS

* AGEX THERAPEUTICS INC - AGEX AND IMSTEM ARE CO-OPERATING TO FINALIZE FINANCIAL TERMS AND OTHER PROVISIONS OF A LICENSE AGREEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below